• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].

作者信息

Koike Kiyomi, Morishige Satoshi, Fukami Kei, Taguchi Kensei, Yakushiji Kazuaki, Okamura Takashi, Okuda Seiya

机构信息

Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Japan.

出版信息

Nihon Naika Gakkai Zasshi. 2011 Jan 10;100(1):179-81. doi: 10.2169/naika.100.179.

DOI:10.2169/naika.100.179
PMID:21387650
Abstract
摘要

相似文献

1
[Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].[病例报告；1例静脉注射唑来膦酸水合物所致急性肾损伤，在1例多发性骨髓瘤患者中采用硼替佐米联合地塞米松治疗后病情改善]
Nihon Naika Gakkai Zasshi. 2011 Jan 10;100(1):179-81. doi: 10.2169/naika.100.179.
2
Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid.在接受硼替佐米、地塞米松和唑来膦酸联合治疗的复发多发性骨髓瘤患者亚组中，骨矿物质密度增加。
Ann Oncol. 2010 Jul;21(7):1561-1562. doi: 10.1093/annonc/mdq259. Epub 2010 May 23.
3
Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma: an open-label, observational, multi-center study in China.硼替佐米联合地塞米松不同剂量方案治疗复发或难治性骨髓瘤：中国一项开放、观察性、多中心研究。
Chin Med J (Engl). 2011 Oct;124(19):2969-74.
4
[Very good partial response and long time to progression by short-term bortezomib plus dexamethasone therapy for a patient with relapsed and refractory multiple myeloma-a case report].[硼替佐米联合地塞米松短期治疗复发性难治性多发性骨髓瘤患者获非常好的部分缓解且疾病进展时间长——病例报告]
Gan To Kagaku Ryoho. 2009 Aug;36(8):1387-9.
5
Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy.皮下注射硼替佐米治疗后进展的多发性骨髓瘤的静脉注射硼替佐米。
Ann Hematol. 2015 Apr;94(4):687-9. doi: 10.1007/s00277-014-2214-x. Epub 2014 Sep 12.
6
Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.在肿瘤溶解综合征发生后，采用硼替佐米/沙利度胺/地塞米松联合疗法使多发性骨髓瘤迅速完全缓解。
Cancer Chemother Pharmacol. 2008 Jun;62(1):181-2. doi: 10.1007/s00280-007-0574-9. Epub 2007 Aug 31.
7
[Case of acute kidney injury related to intravenous zoledronic acid in a patient with multiple myeloma].[一名多发性骨髓瘤患者静脉注射唑来膦酸相关的急性肾损伤病例]
Nihon Jinzo Gakkai Shi. 2009;51(5):557-62.
8
[Unusual skin alterations in a 72-year-old patient with multiple myeloma].[一名72岁多发性骨髓瘤患者的异常皮肤改变]
Internist (Berl). 2012 Apr;53(4):467-73. doi: 10.1007/s00108-011-2996-z.
9
[Clinical study of bortezomib in combination with dexamethasone for the treatment of multiple myeloma].硼替佐米联合地塞米松治疗多发性骨髓瘤的临床研究
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):943-5.
10
[Effective combination therapy of bortezomib and dexamethasone for two patients with refractory multiple myeloma].硼替佐米与地塞米松联合治疗两名难治性多发性骨髓瘤患者的有效性
Rinsho Ketsueki. 2005 Apr;46(4):269-73.